Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,880 total articles

Weyco Reports First Quarter 2026 Results

Weyco Reports First Quarter 2026 Results

Weyco Group, Inc. announced first quarter 2026 financial results with net sales steady at $68 million compared to Q1 2025. Operating earnings rose by 7%, and net earnings increased by 10%, driven by improved cost controls despite tariff-related cost pressures. The company is actively engaging in a tariff refund process following a Supreme Court rul…

OnKure Therapeutics Reports First Quarter 2026 Financial Results

OnKure Therapeutics Reports First Quarter 2026 Financial Results

OnKure Therapeutics reported Q1 2026 financial results highlighting a strategic focus on next-generation PI3Kα pan-mutant selective inhibitors, OKI-355 for vascular anomalies and OKI-345 for breast cancer. The company completed an oversubscribed $150 million private placement, boosting cash reserves to $192 million, expected to fund operations into…

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting

Verrica Pharmaceuticals announced the presentation of Phase 2 clinical data highlighting the potential abscopal effects of their novel oncolytic peptide VP-315 in treating basal cell carcinoma (BCC). The data suggest VP-315 can reduce untreated tumor lesions, indicating broader immune activation that may benefit patients with multiple BCC lesions. …

LeMaitre Q1 2026 Financial Results

LeMaitre Q1 2026 Financial Results

LeMaitre Vascular, a US-based vascular device and implant company, announced robust Q1 2026 financial results featuring an 11% increase in sales to $66.6 million, a 42% rise in EPS to $0.68, and a gross margin improvement to 72.7%. The company cited growth across all major product lines and geographical regions, supported by higher prices and manuf…

Devon Energy Reports First-Quarter 2026 Results

Devon Energy Reports First-Quarter 2026 Results

Devon Energy Corp., a leading U.S. oil and gas producer, reported its first-quarter 2026 financial and operational results and issued an outlook for the second quarter of 2026. The company highlighted its multi-basin portfolio, including a key position in the Delaware Basin, and reaffirmed its commitment to strong returns, free cash flow generation…

Supernus Announces First Quarter 2026 Financial Results

Supernus Announces First Quarter 2026 Financial Results

Supernus Pharmaceuticals (NASDAQ: SUPN) reported a 39% year-over-year increase in total revenues to $207.7 million for Q1 2026, driven by 56% growth in revenues from its four growth products including Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO. The company highlighted ongoing clinical development programs, a potential FDA submission for a second ONAPGO…

Standard BioTools Reports First Quarter 2026 Financial Results

Standard BioTools Reports First Quarter 2026 Financial Results

Standard BioTools Inc. reported first quarter 2026 financial results with revenue of $21.1 million, a 5% increase year-over-year. The company achieved a 54% reduction in operating loss and a 78% improvement in adjusted EBITDA, reinforcing its path to profitability by the end of 2026. Cash and investments totaled $524 million, supporting an aggressi…

Rapid7 Announces First Quarter 2026 Financial Results

Rapid7 Announces First Quarter 2026 Financial Results

Rapid7, Inc. announced its Q1 2026 financial results, reporting annualized recurring revenue (ARR) of $832 million and total revenue of $210 million, slightly down year-over-year. The company posted a GAAP loss from operations of $0.6 million but a non-GAAP operating income of $24 million, with net cash provided by operating activities of $40 milli…

Amwell® Announces Results for First Quarter 2026

Amwell® Announces Results for First Quarter 2026

Amwell, a leading provider of a SaaS-based healthcare technology platform, announced its financial results for Q1 2026 and will hold a conference call to discuss the results. The company continues to offer integrated digital healthcare solutions powering clinical programs for payers and health systems, focusing on enhancing patient access to conven…

SOLOWIN HOLDINGS (AXG)’s AX Coin Signs MOU with Singapore Gulf Bank to Advance Stablecoin and Digital Asset Cooperation

SOLOWIN HOLDINGS (AXG)’s AX Coin Signs MOU with Singapore Gulf Bank to Advance Stablecoin and Digital Asset Cooperation

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that its stablecoin issuance entity, AX Coin, has signed a non-binding Memorandum of Understanding with Singapore Gulf Bank to collaborate on stablecoin infrastructure, cross-border payments, and digital asset initiatives. This partnership aims to integrate AX Coin's compliant stablecoin technology with SGB'…

SuRo Capital Corp. Reports First Quarter 2026 Financial Results

SuRo Capital Corp. Reports First Quarter 2026 Financial Results

SuRo Capital Corp. posted a remarkable first quarter of 2026 with net asset value (NAV) soaring 76% quarter-over-quarter to $14.24 per share, driven by strong portfolio performance and recent financing activities at portfolio companies like WHOOP and OpenAI. The company announced a significant strategic joint venture with Magnetar to form Neostella…

Flywire Reports First Quarter 2026 Financial Results

Flywire Reports First Quarter 2026 Financial Results

Flywire Corporation reported its first quarter 2026 financial results, showing a 41% year-over-year revenue increase to $188.1 million and an adjusted EBITDA growth of 81.8% to $39.3 million. The company signed over 200 new clients across multiple verticals and deepened partnerships in education and travel sectors. An accelerated share repurchase p…

Astera Labs Extends Leadership in Open, AI Scale-Up Networking with New 320 Lane Scorpio X-Series Smart Fabric Switch

Astera Labs Extends Leadership in Open, AI Scale-Up Networking with New 320 Lane Scorpio X-Series Smart Fabric Switch

Astera Labs announced the Scorpio™ X-Series 320 Lane Smart Fabric Switch, the largest open memory-semantic fabric switch targeting large AI scale-up clusters with low latency and improved token economics. Alongside, the company expanded its Scorpio P-Series family, now offering fabric switches from 32 to 320 lanes, enabling flexible, scalable conne…

Latham Group, Inc. Reports First Quarter 2026 Financial Results

Latham Group, Inc. Reports First Quarter 2026 Financial Results

Latham Group, Inc., the largest designer and manufacturer of in-ground residential swimming pools, announced its Q1 2026 financial results showing a 5.3% increase in net sales to $117.3 million and a 220 basis point expansion in gross margin to 31.7%. Adjusted EBITDA rose by 9.2% to $12.2 million, despite a net loss of $8.5 million influenced by hi…

Rush Street Interactive Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders and Concurrent Repurchase of Shares

Rush Street Interactive Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders and Concurrent Repurchase of Shares

Rush Street Interactive, a leading US online casino and sports betting company, has initiated a secondary offering of 10 million Class A shares by key insiders. Concurrently, the company plans to repurchase $30 million of shares from this offering and replace its existing repurchase program with a $100 million new plan. The insiders are selling sto…